Associate Professor Anderson was trained in Microbiology and Molecular Virology at the University of Melbourne and Fairfield Hospital/Burnet Institute under Professor Ian Gust and Stephen Locarnini. He received his PhD in 1989. Since that time his work has focused on understanding the structure and assembly of hepatitis viruses, and the use of this information to design better diagnostics, vaccines and antiviral therapies for control of major viral infections in humans.
Associate Professor Anderson has published more than 60 original research papers and invited chapters. He has presented on original research work at numerous national and international scientific meetings. He has been active in translation of research into practical outcomes through commercial ventures and academic collaborations and is an inventor on 10 patent families.
David A. Anderson
The Lancet. Gastroenterology & hepatology
Jessica Howell, Margaret Hellard, David A. Anderson
BMJ Open
Kate Allardice, Joseph Doyle, Katherine Heath, Imogen Elsum, Caitlin Douglass, Amanda Wade, Sally Von Bibra, Kico Chan, Beatriz Camesella, Rodney Guzman
This project assesses a CD4 test for accelerating initiation of antiretroviral interventions for HIV 1-infected pregnant women in resource-constrained settings.
Congenital syphilis affects more newborns than any other infection (including HIV or tetanus) with many infants dying within the first year of life.